First Patient Treated in Phase III Study with SC Administration of Debio 8206

News   Dec 27, 2012

 
First Patient Treated in Phase III Study with SC Administration of Debio 8206
 
 
 

RELATED ARTICLES

XenoGesis and Juniper Pharma Services Strengthen Alliance

News

Campanies extend strategic alliance in early drug development services.

READ MORE

Study of What Makes Cells Resistant to Radiation Could Improve Cancer Treatments

News

Electron paramagnetic resonance spectroscopy has shown that the same molecular structures provide resistance to the harmful effects of ionizing radiation for every type of living cell found on Earth, from microorganisms to human cells.

READ MORE

Quotient Clinical Signs Cocrystal Agreement with Nuformix

News

Partnership to evaluate cocrystal formulations using translational pharmaceutics.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE